throbber
I[]£] APR MAY JUN
`◄ 08 ►
`lhttp://www.redorbit.com/news/health/1733931/prix galien usa announces 2009 final candidates
`1~1~c-af.!-t-ur-es- - - - - - - - -~~~~~ ~ - -~ ~ ~~- - - - - - - - - -~
`
`8May2015-7Apr2016
`
`edOrbit
`
`YOUR UNI V ERSE O NLINE
`
`2014 2015 2016
`
`..., About this capture
`
`Home
`
`Video
`
`News
`
`Images
`
`Health
`
`Education
`
`Topics
`
`Biogs
`
`Mobile
`
`Space
`
`Science
`
`Technology Health General
`
`Sci-Fi & Gaming Oddities
`
`International
`
`Business
`
`Education Mars Science Laboratory Curiosity
`
`Home ,, News ,, Health ,, Prix Galien USA Announces 2009 Final Candidates
`
`Prix Galien USA Announces 2009 Final Candidates
`August 7, 2009
`
`Related Articles
`
`Honorees for Best Pharmaceutical Agent, Best Biotechnology Product and Best Medical Technology to be
`recognized at Sept. 30 gala ceremony
`
`NEW YORK, Aug. 7 /PRNewswire-USNewswire/ - The 2009 Prix Galien USA will recognize innovative
`biopharmaceutical drugs and medical technologies that have made a deep impact on the quality of human life at a
`gala event on September 30. Candidates for the 2009 program provide relief to millions of people living with chronic
`diseases including cardiovascular disease and diabetes and treatments for people living with cancer and HIV/AIDS.
`The 2009 Prix Galien USA ceremony will again be emceed by Charlie Rose at the American Museum of Natural
`History in New York.
`
`Final candidates for the Prix Galien USA 2009 awards are:
`
`Best Pharmaceutical Agent:
`
`AstraZeneca , CRESTOR(R)
`
`Celgene, Vidaza(R)
`
`Novartis Oncology, GLEEVEC(R)
`
`Novartis Pharmaceuticals, EXELON(R)( )PATCH
`
`Pfizer, Zyvox(R)
`
`Schering-Plough, TEMODAR(R) and ZETIA(R)
`
`Teva Neurosciences, AZILECT(R)
`
`Wyeth, TORISEL(R)
`
`Best Biotechnology Product:
`
`Amgen , Nplate(R)
`
`GlaxoSmithKline, PROMACTA(R) and Tykerb(R)
`
`Schering-Plough, PEGINTRON(R)
`
`Tibotec, INTELENCE(TM)
`
`United Therapeutics, REMODULIN(R)
`
`Wyeth, Prevnar (R)
`
`Best Medical Device:
`
`Abbott Vascular, XIENCE (R)
`
`Boston Scientific, TAXUS (R)
`
`DCA Design, Lantus(R)( )SoloSTAR(R)
`
`Nosebleeds Can Be an Early Warning Sign to More
`Serious Health Problems
`
`HIV vaccines increase infection rates in primate study
`
`Researchers develop cheaper, easier method of
`detecting trace estrogen
`
`"Death from cancer is the best," says doctor
`
`Tired? You may have a magnesium deficiency
`
`NASA Gets Budget Boost In $1 .1 Trillion Spending
`Bill
`
`Is Natural Gas A 'Bridge ' To A Hotter Future?
`
`New Study Indicates That Increased Natural Gas Use
`Will Not Slow Climate Change
`
`T-Mobile 's Future Up In The Air After French Telecom
`Company Iliad Withdraws Takeover Bid
`
`GT Advanced Technologies Files For Bankruptcy
`After Lost Apple Deal
`
`Sanofi Exhibit 2142.001
`Mylan v. Sanofi
`IPR2018-01675
`
`

`

`I[]£] APR MAY JUN
`◄ 08 ►
`lhttp://www.redorbit.com/news/health/1733931/prix galien usa announces 2009 final candidates
`1~1~c-af.!-t-ur-es- - - - - - - - -~~~~~~ - -~~~~ - - - - - - - - - -~
`
`8May2015-7Apr2016
`
`2014 2015 2016
`
`..., About this capture
`
`"Nominees for the Prix Galien USA stand apart from other drugs and technologies In the marketplace for the amount
`of research and level of skill that was invested in the development of these products that improve lives," said Gerald
`Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of
`The FASEB Journal.
`
`Prix Galien USA honorees are judged on the basis of the innovative nature of the development, application or
`clinical utility of the drug or technology and whether its discovery can be applied to future biomedical science.
`
`In 2008, the Prix Galien USA committee recognized Selzentry(TM)( )(Pfizer Inc.), lsentress(R) (Merck & Co., Inc.),
`Soliris(R) (Alexion Pharmaceuticals, Inc.), INFUSE(R) (Wyeth) and Revlimid(R)( )(The Celgene Corporation).
`
`The Prix Galien USA award is considered the industry's highest accolade for pharmaceutical research and
`development - equivalent to the Nobel Prize. The award committee comprises 11 individuals including seven Nobel
`Laureates, founders of major biotech companies and editors of world-renowned biology journals. For details about
`the Prix Galien USA award and committee visit www.Rrix-galien-usa .com .
`
`SOURCE Prix Galien USA
`
`Source: newswire
`
`comments powered by Disqus
`
`Sanofi Exhibit 2142.002
`Mylan v. Sanofi
`IPR2018-01675
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket